ECONOMIC EVALUATION OF ANIDULAFUNGIN FOR CANDIDEMIA OR INVASIVE CANDIDIASIS THERAPY IN KOREA

被引：0
|
作者：
Kim, H. J. [1 ]
Oh, J. J. [1 ]
Park, H. J. [1 ]
Ko, S. K. [1 ]
机构：
[1] Pfizer Pharmaceut Korea Ltd, Seoul, South Korea
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 04期
关键词：
D O I：
10.1016/j.jval.2012.03.1314
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A244 / A244
页数：1
相关论文
共 50 条
  • [21] Invasive candidiasis and candidemia: new guidelines
    De Rosa, F. G.
    Garazzino, S.
    Pasero, D.
    Di Perri, G.
    Ranieri, V. M.
    MINERVA ANESTESIOLOGICA, 2009, 75 (7-8) : 453 - 458
  • [22] An evaluation of Rezafungin: the latest treatment option for adults with candidemia and invasive candidiasis
    Sharma, Divisha
    Vazquez, Jose A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2024, 25 (04) : 339 - 347
  • [23] Cost-effectiveness analysis and budgetary impact of anidulafungin treatment for patients with candidemia and other forms of invasive candidiasis in Brazil
    Vianna, Cid Manso de Mello
    Mosegui, Gabriela Bittencourt Gonzalez
    Rodrigues, Marcus Paulo da Silva
    REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO, 2023, 65
  • [24] Safety, Efficacy and Pharmacokinetics of Anidulafungin in Patients 1 Month to <2 Years of Age With Invasive Candidiasis, Including Candidemia
    Roilides, Emmanuel
    Carlesse, Fabianne
    Tawadrous, Margaret
    Leister-Tebbe, Heidi
    Conte, Umberto
    Raber, Susan
    Swanson, Robert
    Yan, Jean L.
    Aram, Jalal A.
    Queiroz-Telles, Flavio
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2020, 39 (04) : 305 - 309
  • [25] Effectiveness of anidulafungin in eradicating Candida species in invasive candidiasis
    Pfaller, MA
    Diekema, DJ
    Boyken, L
    Messer, SA
    Tendolkar, S
    Hollis, RJ
    Goldstein, BP
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (11) : 4795 - 4797
  • [26] Anidulafungin: Review of its Role in the Treatment of Invasive Candidiasis
    de la Torre, Pola
    Reboli, Annette C.
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2011, 3 : 233 - 243
  • [27] Candidemia and invasive candidiasis in adults: A narrative review
    Antinori, Spinello
    Milazzo, Laura
    Sollima, Salvatore
    Galli, Massimo
    Corbellino, Mario
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2016, 34 : 21 - 28
  • [28] PHARMACOECONOMIC ANALYSIS OF ANIDULAFUNGIN, MICAFUNGIN, CASPOFUNGIN AND FLUCONAZOLE IN THE TREATMENT OF CANDIDEMIA AND/OR INVASIVE CANDIDIASIS IN NON-NEUTROPENIC ADULT PATIENTS IN SPAIN
    Grau, S.
    Pozo, J.
    Roma, E.
    Salavert, M.
    Barrueta, J.
    Peral, C.
    Rodriguez, I
    Rubio-Rodriguez, D.
    Rubio-Terres, C.
    VALUE IN HEALTH, 2015, 18 (07) : A584 - A585
  • [29] Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial
    Vazquez, Jose
    Reboli, Annette C.
    Pappas, Peter G.
    Patterson, Thomas F.
    Reinhardt, John
    Chin-Hong, Peter
    Tobin, Ellis
    Kett, Daniel H.
    Biswas, Pinaki
    Swanson, Robert
    BMC INFECTIOUS DISEASES, 2014, 14
  • [30] Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial
    Jose Vazquez
    Annette C Reboli
    Peter G Pappas
    Thomas F Patterson
    John Reinhardt
    Peter Chin-Hong
    Ellis Tobin
    Daniel H Kett
    Pinaki Biswas
    Robert Swanson
    BMC Infectious Diseases, 14
12345